Multiple beta cell-independent mechanisms drive hypoglycemia in Timothy syndrome

Area of Science:

• Cardiovascular Biology
• Endocrinology
• Genetics

Background:

• Timothy syndrome (TS) is a multisystem disorder caused by a CACNA1C mutation (G406R) leading to increased Ca2+ influx via CaV1.2 channels.
• Life-threatening arrhythmias are a hallmark of TS, but non-cardiac pathologies like severe episodic hypoglycemia remain poorly understood.
• Previous hypotheses linked TS hypoglycemia to hyperinsulinism due to increased Ca2+ influx in pancreatic beta cells, but this lacked direct evidence.

Purpose of the Study:

• To investigate the underlying mechanisms of severe episodic hypoglycemia in Timothy syndrome.
• To determine if hyperinsulinism contributes to hypoglycemia in TS.
• To identify alternative factors regulating glucose homeostasis in the context of the CaV1.2 G406R mutation.

Main Methods:

• Generation of a CaV1.2 G406R knockin mouse model that exhibits TS features, including hypoglycemia.
• Assessment of beta cell function, insulin secretion, and glucose homeostasis in the mouse model.
• Analysis of patient data to confirm or refute hyperinsulinism as a cause of hypoglycemia.
• Evaluation of counterregulatory hormone responses, including glucagon secretion and hypothalamic glucose control.

Main Results:

• The CaV1.2 G406R knockin mice recapitulated TS-associated hypoglycemia but did not exhibit hyperactive beta cells or hyperinsulinism.
• Intrinsic beta cell function remained normal, indicating that the hypoglycemia is not due to excessive insulin secretion.
• Patient data corroborated the absence of hyperinsulinism in individuals with TS.
• Perturbed counterregulatory hormone responses, impaired glucagon secretion, and abnormal hypothalamic glucose regulation were identified as key contributors.

Conclusions:

• Severe episodic hypoglycemia in Timothy syndrome is not caused by hyperinsulinism.
• Dysregulated glucose homeostasis in TS arises from defects in counterregulatory hormone responses and hypothalamic control.
• These findings provide new insights into the non-cardiac manifestations of TS and the role of CaV1.2 channels in integrated glucose metabolism.